Please login to the form below
Mosquirix
This page shows the latest Mosquirix news and features for those working in and with pharma, biotech and healthcare.
Dosing of GSK's malaria vaccine due to start in 2018
GSK's vaccine – also known as Mosquirix – is considered to have limited efficacy, but the sheer scale of the public health problem posed by malaria in some areas of the world
Latest news
-
Malaria vaccine is first to provide 'sustained protection'
The results have been published in the journal Nature Medicine. That data looks pretty good when compared to trials of the Mosquirix malaria vaccine developed by GlaxoSmithKline (GSK) - which has already ... Mosquirix (formerly known as RTS, S) also
-
Shire and Baxalta drugs among CHMP's latest recommendations
Mosquirix outside the EU.
-
World first as CHMP backs GSK malaria vaccine Mosquirix
World first as CHMP backs GSK malaria vaccine Mosquirix. The EMA's scientific advisers recommend its useoutside Europe. ... The CHMP and GSK's biologics unit agreed measures to ensure the safety and effectiveness of Mosquirix is continuously monitored
-
GSK seeks approval for first malaria vaccine
Submits marketing application to European Medicines Agency
-
GSK’s 2011 sales dip but Witty confident for 2012
The remaining three products are skin cancer therapy BRAF, HIV/AIDS treatment dolutegravir and malaria vaccine Mosquirix.
More from news
Approximately 3 fully matching, plus 5 partially matching documents found.
Latest Intelligence
-
Deal Watch January 2018
GSK's malarial vaccine, Mosquirix which also contains Agenus’QS-21 Stimulon, was approved for use by the EMA in 2015.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
-
Scientific Director
-
Great salary and bebefits
- Editor – Medical Education Agency – Bucks
-
Salary TBC
- Senior / Principal Regulatory Writer – Home Working - UK or US
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
-
Senior Medical Writer
-
Great salary and bebefits
- Senior Medical Writer, Medical Communications, Relocate to Cardi...
-
Excellent Salary
- Senior Account Manager – Med Comms – Kent
-
Salary TBC
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
- Senior Account Manager / Account Director
-
Great salary and bebefits
- Principal Medical Writer, Medical Communications, Relocate to Ca...
-
Excellent Salary
- FREELANCE Account Manager – Creative Healthcare Advertising – Lo...
-
SUPERB DAY RATES AVAILABLE
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
- FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...
-
EXCELLENT DAY RATES AVAILABLE
- Editor > Senior Editor – Medical Education – London
-
Very competitive with excellent benefits
-
Senior Programme Executive
-
Salary TBC
- Account Manager – Med Comms – London
-
Salary TBC
-
Senior Medical Writer
-
Great salary and benefits
- Head of Operations/ BUD, Healthcare PR, London – Excellent leade...
-
Excellent Package
Subscribe to our email news alerts
PMHub
Random42 Scientific Communication
Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...
Latest intelligence
- Pharma’s isolated islands of innovation
- With service design and technology often failing the patient, why perspective on improving outcomes need to change...
- Uncertainty, austerity and Brexit
- What does it mean for the life science sector?...
- The Holy Grail of HCP Access
- This is the data you need to gain access....
Quick links
Infographics
